1.610031 成都, 西南交通大学医学院
2.610083 成都, 中国人民解放军西部战区总医院: 重症医学科
3.610083 成都, 中国人民解放军西部战区总医院: 心内科
Received:27 January 2021,
Revised:2021-04-30,
Published:15 August 2021
移动端阅览
Mei LI, Shuang LI, Jian HU, et al. Effect of GSDMD-mediated pyroptosis on muscle atrophy of skeletal muscle in mice and its potential mechanism[J]. Journal of Third Military Medical University, 2021, 43(15): 1486-1492.
Mei LI, Shuang LI, Jian HU, et al. Effect of GSDMD-mediated pyroptosis on muscle atrophy of skeletal muscle in mice and its potential mechanism[J]. Journal of Third Military Medical University, 2021, 43(15): 1486-1492. DOI: 10.16016/j.1000-5404.202101229.
目的
2
探讨脂多糖(lipopolysaccharide,LPS)刺激下小鼠骨骼肌肌管中肌肉萎缩和GSDMD介导的细胞焦亡发生情况,以期为进一步阐明ICU获得性衰弱(ICU-acquired weakness
ICU-AW)的发病机制提供线索。
方法
2
将C2C12小鼠骨骼肌成肌细胞诱导分化形成肌管。分别设置: Control组,加无菌PBS溶液;LPS组,LPS处理浓度梯度为1、10、100 μg/mL;LPS+ATP组,以LPS组相同浓度梯度干预肌管后均添加ATP(5 mmol/L)。并分别在LPS干预6 h和12 h这两个时间点检测肌管内外发生的变化。光镜下观察肌管形态学变化,采用Western blot法检测各组肌管中肌管形成标志蛋白MHC、Myogenin、HDAC1和细胞焦亡标志蛋白GSDMD的表达,采用荧光定量PCR检测各组肌管中萎缩基因Atrogin-1、MuRF-1 mRNA和细胞焦亡相关炎性因子IL-18 mRNA表达,采用ELISA检测肌管培养上清IL-18浓度。
结果
2
① 光镜可见分化第5天肌管形成。②RT-qPCR检测结果显示: LPS干预12 h后LPS/LPS+ATP各组肌管中萎缩基因Atrogin-1和MuRF-1 mRNA的表达均显著上调(
P
<
0.05),与细胞焦亡相关的炎性因子IL-18 mRNA在肌管中的表达趋势相同(
P
<
0.05)。③ELISA检测结果显示: LPS干预12h后各组肌管培养液上清中IL-18浓度显著高于对照组(
P
<
0.05)。④Western blot法检测结果显示: 各组干预的肌管中肌管形成标志蛋白MHC、Myogenin、HDAC1均能稳定表达;LPS/LPS+ATP处理后肌管GSDMD蛋白表达量较对照组显著增加(
P
<
0.05)。
结论
2
在LPS刺激下小鼠骨骼肌肌管中可发生细胞焦亡,并与肌管萎缩相关。
Objective
2
To investigate the occurrence of gasdermin D protein (GSDMD)-mediated pyroptosis and muscle atrophy in mice under lipopolysaccharide (LPS) stimulation in order to elucidate the possible pathogenetic mechanisms of intensive care unit-acquired weakness (ICU-AW).
Methods
2
The mouse skeletal muscle myoblasts (C2C12) were induced to differentiate into myotubes
and then divided into groups as follows: control group (sterile PBS solution)
LPS groups (1
10 and 100 μg/mL)
and LPS+ATP groups (5 mmol/L ATP was added to the corresponding LPS gradient groups). The changes inside and outside the myotubes were detected and compared among groups at the time points of 6 or 12 h after LPS intervention. The morphological changes of myotubes were observed under light microscope; Western blotting was used to determine the myotube formation marker proteins MHC
myogenin and HDAC1
as well as pyroptosis-related protein
GSDMD
in each group; RT-qPCR was employed to test the mRNA expression of atrophic genes Atrogin-1
MuRF-1 and pyroptosis-related proinflammatory cytokine IL-18 in the myotubes of each group; and the IL-18 concentration in the supernatant of myotube culture was detected by ELISA.
Results
2
Myotubes formation was observed on day 5 of differentiation. Under the stimulation of LPS/LPS+ATP
the mRNA levels of Atrogin-1 and MuRF-1 were significantly up-regulated (
P
<
0.05)
and the expression of IL-18 presented a same trend (
P
<
0.05). ELISA results showed that after LPS intervention for 12 h
the concentration of IL-18 in the myotube culture supernatant was significantly higher in the intervention groups than the control group (
P
<
0.05). In addition
the levels of MHC
Myogenin and HDAC1 proteins were stably expressed in the intervention groups
and the expression of GSDMD protein in the LPS/LPS+ATP groups were significantly increased compared with the control group (
P
<
0.05).
Conclusion
2
LPS induces cell pyroptosis in the myotubes of mouse skeletal muscle
which is correlated with the occurrence of muscle atrophy.
VANHOREBEEK I, LATRONICO N, VAN DEN BERGHE G. ICU-acquired weakness[J]. Intens Care Med, 2020, 46(4): 637-653. DOI:10.1007/s00134-020-05944-4.
FRIEDRICH O, REID M B, VAN DEN BERGHE G, et al . The Sick and the weak: Neuropathies/myopathies in the critically ill[J ] . Physiol Rev, 2015, 95(3): 1025-1109. DOI: 10.1152/physrev.00028.2014.
DE JONGHE B, LACHERADE J C, SHARSHAR T, et al . Intensive care unit-acquired weakness: risk factors and prevention[J ] . Crit Care Med, 2009, 37(10 Suppl): S309-S315. DOI: 10.1097/CCM.0b013e3181b6e64c.
STEVENS R D, ZINK E K. Inflammatory signatures in ICU- acquired weakness[J]. Crit Care Med, 2017, 45(6): 1098- 1100. DOI:10.1097/CCM.0000000000002447.
XU B, JIANG M Z, CH U Y, et al . Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice[J ] . J Hepatol, 2018, 68(4): 773-782. DOI: 10.1016/j.jhep.2017.11.040.
ZYCHLINSKY A, PREVOST M C, SANSONETTI P J. Shigella flexneri induces apoptosis in infected macrophages[J]. Nature, 1992, 358(6382): 167-169. DOI:10.1038/358167a0.
COOKSON B T, BRENNAN M A. Pro-inflammatory programmed cell death[J]. Trends Microbiol, 2001, 9(3): 113-114. DOI:10.1016/s0966-842x(00)01936-3.
PFALZGRAFF A, HEINBOCKEL L, SU Q, et al . Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses[J ] . Biochem Pharmacol, 2017, 140: 64-72. DOI: 10.1016/j.bcp.2017.05.015.
SHI J J, ZHAO Y, WANG K, et al . Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J ] . Nature, 2015, 526(7575): 660-665. DOI: 10.1038/nature15514.
ZHENG Z, LI G. Mechanisms and therapeutic regulation of pyroptosis in inflammatory diseases and cancer[J]. Int J Mol Sci, 2020, 21(4): 1456. DOI: 10.3390/ijms21041456.
TANG H B, SHRAGER J B. The signaling network resulting in ventilator-induced diaphragm dysfunction[J]. Am J Respir Cell Mol Biol, 2018, 59(4): 417-427. DOI:10.1165/rcmb.2018-0022TR.
YAO X, YU T, ZHAO C, et al . Evodiamine promotes differentiation and inhibits proliferation of C2C12 muscle cells[J ] . Int J Mol Med, 2018, 41(3): 1627-1634. DOI:10.3892/ijmm.2017.3321.
ZHAO M J, XIE J, SHU W J, et al . MiR-15b and miR-322 inhibit SETD3 expression to repress muscle cell differentiation[J ] . Cell Death Dis, 2019, 10(3): 183. DOI:10.1038/s41419-019-1432-5.
XIA S, HOLLINGSWORTH LRT, WU H. Mechanism and regulation of gasdermin-mediated cell death[J]. Cold Spring Harb Perspect Biol, 2020, 12(3). DOI:10.1101/cshperspect.a036400.
WOLLERSHEIM T, WOEHLECKE J, KREBS M, et al . Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness[J ] . Intens Care Med, 2014, 40(4): 528-538. DOI:10.1007/s00134-014-3224-9.
HERRIDGE M S, CHU L M, MATTE A, et al . The RECOVER program: disability risk groups and 1-year outcome after 7 or more days of mechanical ventilation[J ] . Am J Respir Crit Care Med, 2016, 194(7): 831-844. DOI:10.1164/rccm.201512-2343OC.
JOLLEY S E, BUNNELL A E, HOUGH C L. ICU-Acquired weakness[J]. Chest, 2016, 150(5): 1129-1140.DOI:10.1016/j.chest.2016.03.045.
BATT J, HERRIDGE M S, DOS SANTOS C C. From skeletal muscle weakness to functional outcomes following critical illness: a translational biology perspective[J]. Thorax, 2019, 74(11): 1091-1098. DOI:10.1136/thoraxjnl-2016-208312.
STEVENS R D, MARSHALL S A, CORNBLATH D R, et al . A framework for diagnosing and classifying intensive care unit-acquired weakness[J ] . Crit Care Med, 2009, 37(10 Suppl): S299-S308. DOI: 10.1097/CCM.0b013e3181b6ef67.
FRIEDRICH O, FINK R H, HUND E. Understanding critical illness myopathy: approaching the pathomechanism[J]. J Nutr, 2005, 135(7): 1813S-1817S. DOI:10.1093/jn/135.7.1813S.
ONO Y, SAKAMOTO K. Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-Α[J]. PLoS ONE, 2017, 12(7): e0182040. DOI:10.1371/journal.pone.0182040.
GRIFFITH D M, LEWIS S, ROSSI A G, et al . Systemic inflammation after critical illness: relationship with physical recovery and exploration of potential mechanisms[J ] . Thorax, 2016, 71(9): 820-829. DOI:10.1136/thoraxjnl-2015-208114.
KAYAGAKI N, STOWE I B, LEE B L, et al . Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling[J ] . Nature, 2015, 526(7575): 666-671. DOI:10.1038/nature15541.
XIAO J, WANG C, YAO J C, et al . Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice[J ] . PLoS Biol, 2018, 16(11): e3000047. DOI:10.1371/journal.pbio.3000047.
LI S, WU Y, YANG D, et al . Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis[J ] . J Exp Med, 2019, 216(11): 2562-2581. DOI:10.1084/jem.20190377.
KANNEGANTI A, MALIREDDI RKS, SAAVEDRA PHV, et al . GSDMD is critical for autoinflammatory patholo gy in a mouse model of Familial Mediterranean Fever[J ] . J Exp Med, 2018, 215(6): 1519-1529. DOI:10.1084/jem.20172060.
DOYLE A, ZHANG G, ABDEL FATTAH E A, et al . Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways[J ] . FASEB J, 2011, 25(1): 99-110. DOI:10.1096/fj.10-164152..
PETROF B J. Diaphragm weakness in the critically ill: basic mechanisms reveal therapeutic opportunities[J]. Chest, 2018, 154(6): 1395-1403. DOI:10.1016/j.chest.2018.08.1028.
HOOIJMAN P E, BEISHUIZEN A, WITT C C, et al . Diaphragm muscle fiber weakness and ubiquitin-proteasome activation in critically ill patients[J ] . Am J Respir Crit Care Med, 2015, 191(10): 1126-1138. DOI:10.1164/rccm.201412-2214OC.
MCFARLANE C, PLUMMER E, THOMAS M, et al . Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism[J ] . J Cell Physiol, 2006, 209(2): 501-514. DOI:10.1002/jcp.20757.
PUTHUCHEARY Z A, RAWAL J, MCPHAIL M, et al . Acute skeletal muscle wasting in critical illness[J ] . JAMA, 2013, 310(15): 1591-1600. DOI:10.1001/jama.2013.278481.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
